Status:
WITHDRAWN
Injection Free IVF
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Fertility Disorders
Eligibility:
FEMALE
18-42 years
Phase:
PHASE2
Brief Summary
Investigation of Natural Cycle In vitro Fertilisation (NC-IVF) treatment with ovulation induction with a nasal GnRH agonist instead of regular NC-IVF treatment with subcutaneous application of hCG wit...
Detailed Description
In vitro Fertilisation (IVF) treatments can be performed without gonadotropins to reduce side effects. These kinds of IVF treatments are called Natural Cycle IVF (NC-IVF). As NC-IVFs are almost equall...
Eligibility Criteria
Inclusion
- Indication for IVF
- Wish to perform NC-IVF
- Regular menstruation cycles (26-32 days)
- Orthotopic localization of ovaries
- Age 18-42
- Written informed consent
Exclusion
- Endometrioses III°-IV°
- ≥ 3 embryo transfers in previous IVF therapies without pregnancy
- Contraindications or allergies against study medications
- \< 18 and \> 42 years of age
- Known or suspected non-compliance
- Inability of the participant to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
- Participation in another study with investigational drug within the 30 days preceding and during the present study
- Previous enrolment into the current study
- Enrolment of the investigators, their family members, employees and other dependent persons
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04850261
Start Date
May 1 2021
End Date
March 31 2024
Last Update
October 30 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.